Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialEugenio Mercuri, A. Nascimento, Jean K. Mah et al.|The Lancet Neurology|2024Cited by 128
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trialCraig M. McDonald, Laura Brown, Chet Villa et al.|The Lancet|2026Cited by 0